ImageneBio (IMA) Other Non-Current Liabilities (2023 - 2025)
ImageneBio's (IMA) quarterly Other Non-Current Liabilities came in at $870000.0 in Q4 2025, down 21.48% quarter-over-quarter from $1.1 million in Q3 2025.
Analysis
ImageneBio (IMA) Other Non-Current Liabilities (2023 - 2025) Analysis & Trends
ImageneBio has disclosed Other Non-Current Liabilities across 3 years of filings, most recently posting $870000.0 for Q4 2025.
- In Q4 2025, Other Non-Current Liabilities changed N/A year-over-year to $870000.0; the TTM figure through Dec 2025 stood at $870000.0 (changed N/A YoY), while the FY2025 annual figure was $870000.0, changed N/A from the prior year.
- Other Non-Current Liabilities came in at $870000.0 for Q4 2025 at ImageneBio, down from $1.1 million in the prior quarter.
- In the past five years, Other Non-Current Liabilities ranged from a high of $1.1 million in Q3 2025 to a low of $870000.0 in Q4 2025.
- Average Other Non-Current Liabilities over 3 years is $1.0 million, with a median of $1.0 million recorded in 2024.
- The largest YoY upside for Other Non-Current Liabilities was 11.72% in 2025 against a maximum downside of 5.71% in 2025.
- Over 3 years, Other Non-Current Liabilities stood at $950000.0 in 2023, then gained by 10.0% to $1.0 million in 2024, then dropped by 16.75% to $870000.0 in 2025.
- Per Business Quant data, the three most recent Other Non-Current Liabilities figures were $870000.0 in Q4 2025, $1.1 million in Q3 2025, and $1.1 million in Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn |
| 10 | ImageneBio | 42.89 Mn | -92.46 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 870,000.00 |
| Sep 30, 2025 | 1.11 Mn |
| Jun 30, 2025 | 1.09 Mn |
| Mar 31, 2025 | 1.08 Mn |
| Sep 30, 2024 | 1.05 Mn |
| Jun 30, 2024 | 1.03 Mn |
| Mar 31, 2024 | 964,000.00 |
| Dec 31, 2023 | 950,000.00 |